Mind-altering substances are (still) falling short in clinical trials

This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin—which is found in magic mushrooms—are being explored for all sorts of health applications, including treatments for depression, PTSD, addiction, and even obesity. Over

• Mind-altering substances are (still) falling short in clinical trials
  MIT Tech Review

• Planet Labs - A Short Story 36.0%
• Early COVID-19 pandemic death toll much higher than official count: Study 81.0%
• All Seven Deadly Sins: Origin codes in March 2026 for extra draw tickets, cube keys, and more 56.0%
• Luka drops 60, gets MVP chants from Heat crowd 55.0%
• Tomb Raider is fine, Crystal Dynamics says, as it lays off employees for the fourth time in the past 12 months 55.0%